Clinical Trials Directory

Trials / Sponsors / Guangzhou Patronus Biotech Co., Ltd.

Guangzhou Patronus Biotech Co., Ltd.

Industry · 13 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
Active Not RecruitingA Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years
Herpes Zoster (HZ), Shingles, VZV
Phase 22025-10-23
Active Not RecruitingA Study to Evaluate the Immunogenicity and Safety of a Recombinant Respiratory Syncytial Virus Vaccine in Olde
Respiratory Syncytial Virus Infection Prevention
Phase 22025-10-21
Active Not RecruitingSafety and Immunogenicity of the Recombinant Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 18 Years
Respiratory Syncytial Virus Infection
Phase 12025-04-15
RecruitingSafety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older
Herpes Zoster (HZ)
Phase 12025-03-13
Active Not RecruitingA Safety and Immunogenicity Trial of a Respiratory Syncytial Virus Vaccine, LYB005 in Healthy Adults
Respiratory Syncytial Virus (RSV), RSV Infection
Phase 12024-07-31
Active Not RecruitingA Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70
Herpes Zoster
Phase 12024-03-27
UnknownSafety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vac
SARS-CoV-2, COVID-19 Vaccine
Phase 12023-12-26
UnknownThe Safety and Immunogenicity Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB002
COVID-19
EARLY_Phase 12023-04-25
WithdrawnImmunogenicity and Safety of COVID-19 Vaccine in Population Aged 18 Years and Above
COVID-19
Phase 22023-01-07
TerminatedEfficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or Older
COVID-19
Phase 32022-12-29
UnknownImmunogenicity and Safety of COVID-19 Vaccine as a Booster Vaccination in Population Aged 18 Years and Above
COVID-19
Phase 32022-12-28
UnknownSafety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above
COVID-19
Phase 12022-07-19
UnknownThe Immunogenicity and Safety Following a Heterologous Booster Dose of Recombinant SARS-CoV-2 Vaccine LYB001
COVID-19, Vaccine Reaction
EARLY_Phase 12022-05-14